Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EBS NASDAQ:IMMR NASDAQ:INVE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEBSEmergent Biosolutions$8.93+0.2%$7.97$4.02▼$12.73$475.36M2.03968,556 shs890,701 shsIMMRImmersion$7.33+2.7%$7.09$6.47▼$10.72$231.31M1.25395,081 shs348,348 shsINVEIdentiv$3.52-3.3%$3.65$2.86▼$4.29$86.35M1.3525,532 shs44,307 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEBSEmergent Biosolutions0.00%+8.01%+7.42%+39.50%+18.83%IMMRImmersion0.00%-3.38%+1.13%-9.39%-20.22%INVEIdentiv0.00%-2.15%-1.62%+11.66%+4.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEBSEmergent Biosolutions$8.93+0.2%$7.97$4.02▼$12.73$475.36M2.03968,556 shs890,701 shsIMMRImmersion$7.33+2.7%$7.09$6.47▼$10.72$231.31M1.25395,081 shs348,348 shsINVEIdentiv$3.52-3.3%$3.65$2.86▼$4.29$86.35M1.3525,532 shs44,307 shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEBSEmergent Biosolutions0.00%+8.01%+7.42%+39.50%+18.83%IMMRImmersion0.00%-3.38%+1.13%-9.39%-20.22%INVEIdentiv0.00%-2.15%-1.62%+11.66%+4.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEBSEmergent Biosolutions 3.00Buy$13.5051.26% UpsideIMMRImmersion 3.00Buy$12.2567.12% UpsideINVEIdentiv 3.00Buy$5.3351.52% UpsideCurrent Analyst Ratings BreakdownLatest INVE, IMMR, and EBS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/3/2025EBSEmergent BiosolutionsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$15.008/8/2025INVEIdentivCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.008/8/2025INVEIdentivB. RileySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$6.50 ➝ $6.00(Data available from 9/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEBSEmergent Biosolutions$1.04B0.46$1.92 per share4.64$8.91 per share1.00IMMRImmersion$33.92M7.00$1.10 per share6.69$6.32 per share1.16INVEIdentiv$26.63M3.14N/AN/A$6.45 per share0.55Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEBSEmergent Biosolutions-$190.60M$2.453.644.31N/A16.38%24.63%8.97%11/5/2025 (Estimated)IMMRImmersionN/A$2.782.64∞N/A7.31%21.53%8.75%N/AINVEIdentiv$74.82M$3.041.16N/AN/A308.59%-13.75%-12.80%11/6/2025 (Estimated)Latest INVE, IMMR, and EBS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025INVEIdentiv-$0.31-$0.26+$0.05-$0.26$5.10 million$5.04 million8/6/2025Q2 2025EBSEmergent Biosolutions-$0.26$0.16+$0.42-$0.22$148.55 million$140.90 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEBSEmergent BiosolutionsN/AN/AN/AN/AN/AIMMRImmersion$0.182.46%N/A6.47%N/AINVEIdentivN/AN/AN/AN/AN/ALatest INVE, IMMR, and EBS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/7/2025IMMRImmersionQuarterly$0.04502.28%7/23/20257/23/20258/8/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEBSEmergent Biosolutions1.255.663.00IMMRImmersion0.251.721.04INVEIdentivN/A21.7020.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEBSEmergent Biosolutions78.40%IMMRImmersion60.57%INVEIdentiv65.16%Insider OwnershipCompanyInsider OwnershipEBSEmergent Biosolutions3.20%IMMRImmersion5.50%INVEIdentiv3.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEBSEmergent Biosolutions2,42053.35 million51.64 millionOptionableIMMRImmersion2032.40 million30.61 millionOptionableINVEIdentiv33023.72 million22.87 millionOptionableINVE, IMMR, and EBS HeadlinesRecent News About These Companies3 Small-Cap Stocks to Watch After the Fed’s Rate Cuts (INVE)...September 29 at 9:57 AM | marketbeat.com4 Computer Peripheral Equipment Stocks in Focus in a Thriving IndustrySeptember 29 at 9:05 AM | zacks.comIdentiv (NASDAQ:INVE) Stock Crosses Above 200 Day Moving Average - Time to Sell?September 26 at 3:36 AM | marketbeat.comSmall-Cap Stocks to Watch After the Fed’s Rate Cuts (INVE)...September 24, 2025 | marketbeat.comIdentiv Insiders Added US$2.07m Of Stock To Their HoldingsSeptember 24, 2025 | finance.yahoo.comIdentiv (NASDAQ:INVE) Shares Pass Above Two Hundred Day Moving Average - Here's What HappenedSeptember 18, 2025 | americanbankingnews.comIdentiv (NASDAQ:INVE) Shares Pass Above 200-Day Moving Average - Here's WhySeptember 18, 2025 | marketbeat.comIdentiv (NASDAQ:INVE) Shares Pass Above 200 Day Moving Average - Time to Sell?September 10, 2025 | marketbeat.comIdentiv management to meet virtually with Lake StreetSeptember 9, 2025 | msn.comIdentiv (NASDAQ:INVE) Upgraded to "Hold" at Wall Street ZenSeptember 1, 2025 | marketbeat.comIdentiv Appoints Ed Kirnbauer as New CFOAugust 9, 2025 | theglobeandmail.comIdentiv, Inc. (INVE) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comIdentiv’s Q2 2025 Results Highlight Strategic ShiftsAugust 8, 2025 | msn.comIdentiv (INVE) Q2 Revenue Drops 25%August 7, 2025 | fool.comIdentiv, Inc. (INVE) Reports Q2 Loss, Lags Revenue EstimatesAugust 7, 2025 | zacks.comIdentiv Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | prnewswire.comIFCO and Identiv Form Strategic Partnership to Enhance Digital Traceability in the Global Fresh Grocery Supply ChainAugust 4, 2025 | prnewswire.comIdentiv Sets Second Quarter 2025 Earnings Call for Thursday, August 7, 2025, at 5:00 PM EDTJuly 17, 2025 | prnewswire.comIdentiv, Inc. (INVE) - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comIdentiv, Narravero Partner to Accelerate DPP ComplianceJuly 10, 2025 | rfidjournal.comRINVE | Identiv Inc. Quarterly Income Statement - MarketWatchJuly 9, 2025 | marketwatch.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 20252 Falling Knives That Might Be Worth CatchingBy Sam Quirke | September 16, 2025These 3 Stocks Are Shielded From the AI TakeoverBy Gabriel Osorio-Mazilli | September 15, 2025Joby Aviation's Pullback: A Gift for Investors Who See the FutureBy Jeffrey Neal Johnson | September 2, 2025Is Super Micro Next in Line for a Big AI Takeover?By Gabriel Osorio-Mazilli | September 23, 2025INVE, IMMR, and EBS Company DescriptionsEmergent Biosolutions NYSE:EBS$8.93 +0.02 (+0.17%) Closing price 03:59 PM EasternExtended Trading$8.83 -0.10 (-1.06%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.Immersion NASDAQ:IMMR$7.33 +0.19 (+2.66%) Closing price 04:00 PM EasternExtended Trading$7.32 0.00 (-0.07%) As of 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immersion Corporation, together with its subsidiaries, engages in the creation, design, development, and licensing of haptic technologies that allow people to use their sense of touch to engage with and experience various digital products in North America, Europe, and Asia. The company provides technology, patent, and combined licenses. It serves markets, including mobility, gaming, automotive, virtual and augmented reality, and wearables, as well as residential, commercial, and industrial Internet of Things. The company was incorporated in 1993 and is headquartered in Aventura, Florida.Identiv NASDAQ:INVE$3.52 -0.12 (-3.30%) Closing price 04:00 PM EasternExtended Trading$3.52 0.00 (0.00%) As of 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Identiv, Inc., a security technology company, that provides secure identification and physical security solutions that secure things, data, and physical places worldwide. It operates in two segments, Identity and Premises. The Identity segment offers products and solutions that enables secure access to information serving the logical access and cyber security markets, as well as protecting connected objects and information using radio-frequency identification embedded security. The Premises segment provides solutions for premises security market, such as access control, video surveillance, analytics, audio, access readers, and identities to government facilities, schools, utilities, hospitals, stores, and apartment buildings. The company sells its products through dealers, systems integrators, value added resellers, and resellers. The company was formerly known as Identive Group, Inc. and changed its name to Identiv, Inc. in May 2014. Identiv, Inc. was founded in 1990 and is headquartered in Fremont, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Top-Rated Dividend Growth Stocks to Buy in October Top Insider Buys and Sells From September: Buy, Sell, or Hold? This ETF Weeds Out Small-Cap Underperformers Dividend ETF SCHD Draws Buyers as Fed Cuts Spark Rotation Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300 MarketBeat Week in Review – 09/22 - 09/26 Get Exposure to Millennials' Purchasing Power With This ETF Beam Global Gets Buy Rating With 101% Upside Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
